SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced financial results for the fourth quarter and fiscal year 2015, which ended June 30, 2015.
Fourth quarter 2015 revenue of $510.1 million decreased 2% as reported but increased 8% in constant currency from $519.6 million in the fourth quarter a year ago.
Help employers find you! Check out all the jobs and post your resume.
Fourth quarter 2015 revenue of $510.1 million decreased 2% as reported but increased 8% in constant currency from $519.6 million in the fourth quarter a year ago.
Help employers find you! Check out all the jobs and post your resume.
